These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1357806)

  • 1. [Significance of free oxygen radicals for pathogenesis of chronic inflammatory disease].
    Nielsen OH; Ahnfelt-Rønne I
    Ugeskr Laeger; 1992 Sep; 154(38):2544-6. PubMed ID: 1357806
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract]   [Full Text] [Related]  

  • 3. Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
    Banatwala N
    J Pak Med Assoc; 1985 Mar; 35(3):64-8. PubMed ID: 2860256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic experience with ulcerative colitis and Crohn disease].
    Nagy G; Prónay G; Ujszászy L
    Orv Hetil; 1985 Jan; 126(1):17-20, 23-4. PubMed ID: 2857480
    [No Abstract]   [Full Text] [Related]  

  • 5. [New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
    Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1987 Apr; 11(4):325-32. PubMed ID: 2884162
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunomodulation treatment of inflammatory bowel disease].
    Stave R
    Tidsskr Nor Laegeforen; 1984 Jan; 104(3):153-4. PubMed ID: 6142543
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug management of inflammatory bowel disease.
    McCarthy CF
    Ir Med J; 1983 May; 76(5):260-2. PubMed ID: 6135675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mode of action of sulfasalazine in chronic inflammatory enterocolonic diseases].
    Delboy H
    Therapie; 1992; 47(2):157-9. PubMed ID: 1357770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
    Maier KP
    Dtsch Med Wochenschr; 1992 Oct; 117(42):1614-5. PubMed ID: 1356747
    [No Abstract]   [Full Text] [Related]  

  • 12. 1986 Stuart distinguished lecture. The "natural history" of inflammatory bowel disease and therapeutic decisions.
    Janowitz HD
    Am J Gastroenterol; 1987 Jun; 82(6):498-503. PubMed ID: 2883884
    [No Abstract]   [Full Text] [Related]  

  • 13. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inflammatory bowel diseases].
    Kruis W
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S73-5. PubMed ID: 15368174
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of recurrence of chronic inflammatory bowel diseases].
    Dölle W; Hartmann F
    Verh Dtsch Ges Inn Med; 1989; 95():322-6. PubMed ID: 2574922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE
    Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
    [No Abstract]   [Full Text] [Related]  

  • 18. [5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
    Cappello M; Puleo A; Calabrese A; Cipolla C; Orlando A; Gatto G; Oliva L; Cottone M
    Recenti Prog Med; 1987 Feb; 78(2):76-8. PubMed ID: 2884701
    [No Abstract]   [Full Text] [Related]  

  • 19. [New developments in the treatment of inflammatory bowel diseases. What is certain?].
    Feurle GE
    Z Gastroenterol Verh; 1990 Apr; 25():150-2. PubMed ID: 1694355
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ulcerative colitis and Crohn disease. Early diagnosis and therapy].
    Wienbeck M; Purrmann J; Miller B
    Internist (Berl); 1986 Mar; 27(3):166-71. PubMed ID: 2872183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.